{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:42:52Z","timestamp":1791330172784,"version":"4.3.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573488"],"award-info":[{"award-number":["81573488"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Young Scientist Special Projects in biotechnological and pharmaceutical field","award":["2015AA020916"],"award-info":[{"award-number":["2015AA020916"]}]},{"name":"Outstanding Youth Fund from the Natural Science Foundation of Guangdong Province","award":["2014A030306014"],"award-info":[{"award-number":["2014A030306014"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2015A030310339"],"award-info":[{"award-number":["2015A030310339"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ijpharm.2016.01.067","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T15:30:20Z","timestamp":1454427020000},"page":"190-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cremophor EL-based nanoemulsion enhances transcellular permeation of emodin through glucuronidation reduction in UGT1A1-overexpressing MDCKII cells"],"prefix":"10.1016","volume":"501","author":[{"given":"Tianpeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ijpharm.2016.01.067_bib0005","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.drudis.2014.04.011","article-title":"Is nanotechnology a boon for oral drug delivery?","volume":"19","author":"Agrawal","year":"2014","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.ijpharm.2016.01.067_bib0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.23359","article-title":"The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development","volume":"102","author":"Benet","year":"2013","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijpharm.2016.01.067_bib0015","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ejps.2013.03.008","article-title":"Nanocarrier systems for oral drug delivery: do we really need them?","volume":"49","author":"Bernkop-Schn\u00fcrch","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.01.067_bib0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bdd.383","article-title":"In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam","volume":"25","author":"Bravo Gonzalez","year":"2004","journal-title":"Biopharm. Drug Dispos."},{"issue":"4","key":"10.1016\/j.ijpharm.2016.01.067_bib0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1139\/y2012-004","article-title":"Characteristics of emodin on modulating the contractility of jejunal smooth muscle","volume":"90","author":"Chen","year":"2012","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2016.01.067_bib0030","doi-asserted-by":"crossref","first-page":"357357","DOI":"10.1155\/2015\/357357","article-title":"Naturally occurring anthraquinones: chemistry and therapeutic potential in autoimmune diabetes","volume":"2015","author":"Chien","year":"2015","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"1","key":"10.1016\/j.ijpharm.2016.01.067_bib0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/bj1370143","article-title":"A simple graphical method for determining the inhibition constants of mixed, uncompetitive and noncompetitive inhibitors","volume":"137","author":"Cornish-Bowden","year":"1974","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.ijpharm.2016.01.067_bib0040","doi-asserted-by":"crossref","first-page":"E323","DOI":"10.1208\/pt060242","article-title":"Development of a dialysis in vitro release method for biodegradable microspheres","volume":"6","author":"D\u2019Souza","year":"2005","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2016.01.067_bib0045","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jpba.2015.06.027","article-title":"Effect of piperine on the bioavailability and pharmacokinetics of emodin in rats","volume":"115","author":"Di","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.ijpharm.2016.01.067_bib0050","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.biomed.2012.03.003","article-title":"Anticancer potential of emodin","volume":"2","author":"Hsua","year":"2012","journal-title":"BioMedicine"},{"issue":"5","key":"10.1016\/j.ijpharm.2016.01.067_bib0055","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/s-2006-958125","article-title":"Emodin pharmacokinetics in rabbits","volume":"61","author":"Liang","year":"1995","journal-title":"Planta Med."},{"issue":"4","key":"10.1016\/j.ijpharm.2016.01.067_bib0060","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1124\/dmd.30.4.370","article-title":"Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model","volume":"30","author":"Liu","year":"2002","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.ijpharm.2016.01.067_bib0065","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1208\/s12248-010-9200-6","article-title":"Species and gender differences affect the metabolism of emodin via glucuronidation","volume":"12","author":"Liu","year":"2010","journal-title":"AAPS J."},{"issue":"3","key":"10.1016\/j.ijpharm.2016.01.067_bib0070","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1021\/mp100012s","article-title":"Paclitaxel nanocrystals for overcoming multidrug resistance in cancer","volume":"7","author":"Liu","year":"2010","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.ijpharm.2016.01.067_bib0075","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.taap.2012.08.032","article-title":"Coupling of UDP-glucuronosyltransferases and multidrug resistance-associated proteins is responsible for the intestinal disposition and poor bioavailability of emodin","volume":"265","author":"Liu","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"9","key":"10.1016\/j.ijpharm.2016.01.067_bib0080","first-page":"15413","article-title":"ROS\/p38\/p53\/Puma signaling pathway is involved in emodin-induced apoptosis of human colorectal cancer cells","volume":"8","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"4","key":"10.1016\/j.ijpharm.2016.01.067_bib0085","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3892\/ijo.2015.2888","article-title":"The anthraquinone derivative emodin inhibits angiogenesis and metastasis through downregulating Runx2 activity in breast cancer","volume":"46","author":"Ma","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.ijpharm.2016.01.067_bib0090","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1021\/mp900258z","article-title":"Interplay of transporters and enzymes in drug and metabolite processing","volume":"6","author":"Pang","year":"2009","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.ijpharm.2016.01.067_bib0095","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40262-015-0242-x","article-title":"Oral bioavailability: issues and solutions via nanoformulations","volume":"54","author":"Pathak","year":"2015","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.ijpharm.2016.01.067_bib0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1124\/dmd.114.061598","article-title":"Characterization of chrysin glucuronidation in UGT1A1-overexpressing HeLa cells: elucidating the transporters responsible for efflux of glucuronide","volume":"43","author":"Quan","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.ijpharm.2016.01.067_bib0105","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.biocel.2013.02.019","article-title":"The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification","volume":"45","author":"Rowland","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.ijpharm.2016.01.067_bib0110","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/jps.21978","article-title":"Differences in pharmacokinetics and ex vivo antioxidant activity following intravenous and oral administrations of emodin to rats","volume":"99","author":"Shia","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.01.067_bib0115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10973-011-1759-3","article-title":"Emodin\u2013phospholipid complex: a potential of herbal drug in the novel drug delivery system","volume":"108","author":"Singh","year":"2012","journal-title":"J. Therm. Anal Calorim."},{"issue":"8","key":"10.1016\/j.ijpharm.2016.01.067_bib0120","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1074\/jbc.M112.441477","article-title":"Emodin regulates glucose utilization by activating AMP-activated protein kinase","volume":"288","author":"Song","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2016.01.067_bib0125","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/med.20095","article-title":"Molecular mechanism of emodin action: transition from laxative ingredient to an antitumor agent","volume":"27","author":"Srinivas","year":"2007","journal-title":"Med. Res. Rev."},{"issue":"6","key":"10.1016\/j.ijpharm.2016.01.067_bib0130","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1021\/mp8000556","article-title":"Nanoemulsion preparations of the anticancer drug dacarbazine significantly increase its efficacy in a xenograft mouse melanoma model","volume":"5","author":"Tagne","year":"2008","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.ijpharm.2016.01.067_bib0135","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/dmd.106.009738","article-title":"Inhibition of UDP-glucuronosyltransferase 2b7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive mode","volume":"34","author":"Takeda","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.ijpharm.2016.01.067_bib0140","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1021\/mp2004912","article-title":"pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery","volume":"9","author":"Varma","year":"2012","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.ijpharm.2016.01.067_bib0145","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3892\/or.2013.2741","article-title":"The distinct mechanisms of the antitumor activity of emodin in different types of cancer (review)","volume":"30","author":"Wei","year":"2013","journal-title":"Oncol. Rep."},{"issue":"9","key":"10.1016\/j.ijpharm.2016.01.067_bib0150","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1002\/jps.22568","article-title":"First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics","volume":"100","author":"Wu","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.01.067_bib0155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cbi.2014.05.006","article-title":"In vitro glucuronidation of five rhubarb anthraquinones by intestinal and liver microsomes from humans and rats","volume":"219","author":"Wu","year":"2014","journal-title":"Chem. Biol. Interact."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2016.01.067_bib0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2011.05.075","article-title":"Preparation and antitumor study of camptothecin nanocrystals","volume":"415","author":"Zhang","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ijpharm.2016.01.067_bib0165","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/1061186X.2013.789033","article-title":"Nanocarriers for oral drug delivery","volume":"21","author":"Zhang","year":"2013","journal-title":"J. Drug Target."},{"issue":"4","key":"10.1016\/j.ijpharm.2016.01.067_bib0170","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1021\/mp5008019","article-title":"Stable knock-down of efflux transporters leads to reduced glucuronidation in UGT1A1-overexpressing HeLa cells: the evidence for glucuronidation-transport interplay","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2016.01.067_bib0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.fitote.2014.04.002","article-title":"The laxative effect of emodin is attributable to increased aquaporin 3 expression in the colon of mice and HT-29 cells","volume":"96","author":"Zheng","year":"2014","journal-title":"Fitoterapia"},{"issue":"4","key":"10.1016\/j.ijpharm.2016.01.067_bib0180","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1021\/mp5005838","article-title":"Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions","volume":"12","author":"Zhou","year":"2015","journal-title":"Mol. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316300679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316300679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T02:30:29Z","timestamp":1567564229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316300679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0378517316300679"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.01.067","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cremophor EL-based nanoemulsion enhances transcellular permeation of emodin through glucuronidation reduction in UGT1A1-overexpressing MDCKII cells","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.01.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}